NCT06097130

Brief Summary

The correlation between diet and microbiota as well as the effect of microbiota on human health is well established. Studies have shown that people following specific diets have different microbiome profile compared to those following traditional or ordinary diets. In order to screen several food ingredients for their effects on human microbiota composition and metabolic activities, in vitro studies are proposed. Nutrients are added in-vitro in fecal sample, eliminating the need for participants to consume any nutritional product. The batch fermentation in vitro system simulates human colonic microbiota from fecal samples, enabling the complex mixture of microorganisms. This system could serve as a simple model to simulate the diversity as well as the metabolism of human colonic microbiota. We will evaluate the effect on nutrient/s on the age specific microbiome via an in vitro fermentation approach for the 0 to 60 year-old period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 18, 2020

Completed
7 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 25, 2020

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

March 16, 2023

Completed
7 months until next milestone

First Posted

Study publicly available on registry

October 24, 2023

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 26, 2025

Completed
Last Updated

December 18, 2025

Status Verified

December 1, 2025

Enrollment Period

7 days

First QC Date

March 16, 2023

Last Update Submit

December 11, 2025

Conditions

Keywords

Microbiome

Outcome Measures

Primary Outcomes (1)

  • Change in microbiota composition

    Measured by 16s rRNA sequencing or next Generation Sequencing (NGS) or by qPCR

    Through study completion, an average of 1 year

Secondary Outcomes (3)

  • Change in Short Chain Fatty Acids (SCFA)

    Through study completion, an average of 1 year

  • Change in metabolic profile

    Through study completion, an average of 1 year

  • Protein expression of epithelial cells

    Through study completion, an average of 1 year

Eligibility Criteria

Age0 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Healthy population

You may qualify if:

  • Healthy participant aged from 0 to 60 (based on medical history, physical examination and review of childhood growth chart)
  • Written informed consent has been obtained from the parent(s)/legally acceptable representative (LAR) of toddlers and teenagers
  • Written informed consent has been obtained for participants aged from 14 years old and above
  • Child's parent(s)/legal representative or participant is willing and able to fulfill the requirements of the study protocol.
  • Ability to collect their or their infant/child's fecal sample.

You may not qualify if:

  • The parent(s)/legally acceptable representative (LAR) is not able to provide evidence of parental authority or legal representation.
  • Participant following a particular regimen of any type such as vegan, vegetarian, ketogenic, paleo diet,
  • Chronic or recurrent diarrhea with spontaneous bowel movements more often than 2 times daily,
  • Antibacterial/antifungal therapy during the 3 months prior to study enrolment,
  • Medications or supplements that are known to alter gut function or microbiota (i.e. acid antisecretory drugs, pre-/probiotics supplements, laxatives) during the 4 weeks prior to study enrolment,
  • Prior gastrointestinal surgery (apart from appendectomy, cholecystectomy or herniotomy),
  • Alcohol intake higher than 2 servings per day. A serving is 0.4 dl of strong alcohols, 1 dl of red or white wine, or 3 dl of beer,
  • Artificially sweetened beverage intake higher than 1000 ml/ per day,
  • Current or history of gastrointestinal diseases like (Celiac Disease, Crohn's Disease, Ulcerative colitis, Irritable Bowel Syndrome, infantile colic, recurrent abdominal pain, functional constipation, ulcers, infections (based on anamnesis),
  • Participants participating in another interventional study,
  • Participants/parents having a hierarchical or family link with the research team members.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nestle Clinical Innovation Lab

Lausanne, Canton of Vaud, 1000, Switzerland

Location

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 16, 2023

First Posted

October 24, 2023

Study Start

August 18, 2020

Primary Completion

August 25, 2020

Study Completion

March 26, 2025

Last Updated

December 18, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations